Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.
Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.
Coverage includes:
? Novel therapeutic strategies
? High-throughput screening
? Therapeutic targets
? Combinatorial chemistry, parallel synthesis and library design
? Drug delivery
? ADME/Tox
? Advances in key compound classes and therapeutic areas
? Genomics and proteomics
? Automation and technology
? Virtual chemistry
? Informatics
? Business strategy
? Clinical trials
and other aspects of drug discovery.
《Drug Discovery Today》是一本由ELSEVIER SCI LTD出版商出版的专业医学期刊,该刊创刊于1996年,刊期Semimonthly,该刊已被国际权威数据库SCIE、SCI收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:医学 2区,小类学科:药学 1区;在JCR(Journal Citation Reports)分区等级为Q1。该刊发文范围涵盖药学等领域,旨在及时、准确、全面地报道国内外药学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等,促进学术交流,鼓励学术创新。2021年影响因子为8.369,平均审稿速度约6.0个月。
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 2区 | PHARMACOLOGY & PHARMACY 药学 | 2区 | 否 | 是 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q1 | PHARMACOLOGY & PHARMACY | Q1 | 8.369 |
影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
8.369 | 157 | 15.42% | 0.38% | 未开放 | 约6.0个月 |